Dan M. Granoff
27Patents
9h-index
14Co-inventors
72Inventor score
Filing activity: Aug 27, 1997 → Oct 30, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8968748B2 | GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis | Emerging Cross-Sectional Technologies | 37 | Active |
| US6048527A | Antibodies that define unique Meningococcal B epitopes and vaccine compositions | Emerging Cross-Sectional Technologies | 29 | Expired |
| US6936261B2 | Vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis | Human Necessities | 27 | Expired |
| US8470340B2 | Peptides presenting an epitope of a domain of factor H binding protein and methods of use | Human Necessities | 25 | Active |
| US6413520B1 | Methods of immunizing adults using anti-meningococcal vaccine compositions | Human Necessities | 19 | Expired |
| US6030619A | Molecular mimetics of meningococcal B epitopes | Emerging Cross-Sectional Technologies | 18 | Expired |
| US9266942B2 | Chimeric factor H binding proteins (fHbp) and methods of use | Chemistry; Metallurgy | 14 | Active |
| US8007815B1 | Combination meningitidis B/C vaccines | Emerging Cross-Sectional Technologies | 11 | Expired |
| US9827300B2 | Factor H binding proteins (FHBP) with altered properties and methods of use thereof | Human Necessities | 9 | Active |
| US9034345B2 | GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis | Emerging Cross-Sectional Technologies | 7 | Active |
| US8476032B2 | Complement factor H-based assays for serum bactericidal activity against Neisseria meningitidis | Physics | 7 | Active |
| US7534444B2 | Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies | Emerging Cross-Sectional Technologies | 6 | Expired |
| US7595307B2 | Polysaccharide derivatives and uses in induction of an immune response | Emerging Cross-Sectional Technologies | 5 | Expired |
| US9452208B2 | GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis | Emerging Cross-Sectional Technologies | 4 | Active |
| US10046043B2 | GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis | Emerging Cross-Sectional Technologies | 3 | Active |
| US6642354B2 | Molecular mimetics of unique Neisseria meningitidis serogroup B epitopes | Emerging Cross-Sectional Technologies | 2 | Expired |
| US10342860B2 | Factor H binding proteins (FHBP) with altered properties and methods of use thereof | Human Necessities | 2 | Active |
| US10905754B2 | Factor H binding proteins (fHbp) with altered properties and methods of use thereof | Human Necessities | 2 | Active |
| US8663940B2 | Ex-vivo passive protection bacteremia assay | Physics | 2 | Active |
| US7063949B2 | Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroup B epitopes | Emerging Cross-Sectional Technologies | 1 | Expired |
| US10478484B2 | GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis | Emerging Cross-Sectional Technologies | 1 | Active |
| US10857221B2 | GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis | Emerging Cross-Sectional Technologies | 1 | Active |
| US9439957B2 | Factor H binding proteins (FHBP) with altered properties and methods of use thereof | Human Necessities | 1 | Active |
| US11801293B2 | GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis | Emerging Cross-Sectional Technologies | 0 | Active |
| US7504254B2 | Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroup B epitopes | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.